Page last updated: 2024-08-23

pravastatin and d-4f peptide

pravastatin has been researched along with d-4f peptide in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anantharamaiah, GM; Fogelman, AM; Frank, JS; Garber, DW; Hama, S; Handattu, S; Hough, G; Navab, M; Reddy, ST1
Banquerigo, ML; Brahn, E; Charles-Schoeman, C; Fogelman, AM; Hama, S; Navab, M; Park, GS; Van Lenten, BJ; Wagner, AC1
Anantharamaiah, GM; Fogelman, AM; Hama, S; Hough, G; Lehrer, RI; Navab, M; Palgunachari, MN; Ruchala, P; Waring, AJ1
Anantharamaiah, GM; Cao, D; Garber, DW; Handattu, SP; Kadish, I; Li, L; Monroe, CE; Nayyar, G; Palgunachari, MN; van Groen, T1

Other Studies

4 other study(ies) available for pravastatin and d-4f peptide

ArticleYear
D-4F and statins synergize to render HDL antiinflammatory in mice and monkeys and cause lesion regression in old apolipoprotein E-null mice.
    Arteriosclerosis, thrombosis, and vascular biology, 2005, Volume: 25, Issue:7

    Topics: Age Factors; Animal Feed; Animals; Anti-Inflammatory Agents; Apolipoprotein A-I; Apolipoproteins E; Atherosclerosis; Cells, Cultured; Chemotaxis, Leukocyte; Cholesterol, HDL; Drug Synergism; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intestinal Mucosa; Macaca fascicularis; Male; Mice; Mice, Mutant Strains; Monocytes; Pravastatin

2005
Treatment with an apolipoprotein A-1 mimetic peptide in combination with pravastatin inhibits collagen-induced arthritis.
    Clinical immunology (Orlando, Fla.), 2008, Volume: 127, Issue:2

    Topics: Animals; Antibodies; Anticholesteremic Agents; Apolipoprotein A-I; Arthritis, Experimental; Arthritis, Rheumatoid; Chemotaxis; Cholesterol, HDL; Collagen Type II; Cytokines; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Histocytochemistry; Humans; Joints; Monocytes; Pravastatin; Radiography; Random Allocation; Rats; Regression Analysis

2008
A novel method for oral delivery of apolipoprotein mimetic peptides synthesized from all L-amino acids.
    Journal of lipid research, 2009, Volume: 50, Issue:8

    Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Apolipoprotein A-I; Apolipoproteins E; Atherosclerosis; Biological Availability; Female; Humans; Inflammation; Lipoproteins; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Molecular Mimicry; Niclosamide; Peptides; Pravastatin; Protein Structure, Secondary

2009
Oral apolipoprotein A-I mimetic peptide improves cognitive function and reduces amyloid burden in a mouse model of Alzheimer's disease.
    Neurobiology of disease, 2009, Volume: 34, Issue:3

    Topics: Administration, Oral; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Anticholesteremic Agents; Apolipoprotein A-I; Astrocytes; Chemokine CCL2; Cholesterol; Cognition; Disease Models, Animal; Drug Therapy, Combination; Hippocampus; Interleukin-1beta; Male; Maze Learning; Mice; Mice, Transgenic; Microglia; Plaque, Amyloid; Pravastatin; Protease Nexins; Receptors, Cell Surface; Tumor Necrosis Factor-alpha

2009